Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin
- PMID: 25045456
- PMCID: PMC4103499
- DOI: 10.4084/MJHID.2014.048
Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin
Abstract
The epidemiology of Hodgkin lymphoma (HL) has always been a source of fascination to researchers due to its heterogeneous characteristics of presentation. HL is an uncommon neoplasm of B-cell origin with an incidence that varies significantly by age, sex, ethnicity, geographic location and socioeconomic status. This complex pattern was also found to be replicated among Mediterranean basin populations. HL incidence rates progressively decreased from industrialized European countries such as France (ASR=2.61) and Italy (ASR=2.39) to less developed nations such as Albania (ASR=1.34) and Bosnia Herzegovina (ASR=1.1). Regarding HL mortality we have found that countries with the lowest incidence rates show the highest number of deaths from this cancer and viceversa. Finally, a wide gap in terms of survival was showed across the Mediterranean basin with survival rates ranged from 82.3% and 85.1% among Italian men and women, to 53.3 % and 59.3% among Libyan men and women, respectively. Factors such as the degree of socio-economic development, the exposure to risk factors westernization-related, the availability of diagnostic practices along with different genetic susceptibilities to HL may explain its variation across Mediterranean countries. Furthermore, the lack of health resources decisively contribute to the poor prognosis recorded in less developed region. In the future, the introduction of appropriate and accessible treatment facilities along with an adequate number of clinical specialists in the treatment of HL and other cancers are warranted in order to improve the outcomes of affected patients and treat a largely curable type of cancer in disadvantaged regions.
Figures
Similar articles
-
[Report on health status of residents in areas with industrial, mining or military sites in Sardinia, Italy].Epidemiol Prev. 2006 Jan-Feb;30(1 Suppl 1):5-95. Epidemiol Prev. 2006. PMID: 16826748 Italian.
-
Italian cancer figures, report 2012: Cancer in children and adolescents.Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. Epidemiol Prev. 2013. PMID: 23585445 English, Italian.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Hodgkin Lymphoma in People Living with HIV.Cancers (Basel). 2021 Aug 29;13(17):4366. doi: 10.3390/cancers13174366. Cancers (Basel). 2021. PMID: 34503176 Free PMC article. Review.
-
On the aetiology of Hodgkin lymphoma.Dan Med J. 2012 Jul;59(7):B4485. Dan Med J. 2012. PMID: 22759852 Review.
Cited by
-
Epidemiologic Associations Between Inflammatory Bowel Disease and Hodgkin Lymphoma or Multiple Sclerosis.Gastro Hep Adv. 2024 Mar 26;3(5):605-611. doi: 10.1016/j.gastha.2024.03.013. eCollection 2024. Gastro Hep Adv. 2024. PMID: 39165410 Free PMC article.
-
Association of TLR9-1237T>C; rs5743836 polymorphism with increased risk of Hodgkin's lymphoma: A case-control study.PLoS One. 2022 Jul 29;17(7):e0272312. doi: 10.1371/journal.pone.0272312. eCollection 2022. PLoS One. 2022. PMID: 35905120 Free PMC article.
-
Molecular Genetics in Epstein-Barr Virus-Associated Malignancies.Life (Basel). 2021 Jun 22;11(7):593. doi: 10.3390/life11070593. Life (Basel). 2021. PMID: 34206255 Free PMC article. Review.
-
NFATc1 is Suppressed in Tumor Microenvironment of Hodgkin Lymphoma.Asian Pac J Cancer Prev. 2021 Jun 1;22(6):1943-1948. doi: 10.31557/APJCP.2021.22.6.1943. Asian Pac J Cancer Prev. 2021. PMID: 34181355 Free PMC article.
-
Hodgkin Reed-Sternberg-Like Cells in Non-Hodgkin Lymphoma.Diagnostics (Basel). 2020 Nov 27;10(12):1019. doi: 10.3390/diagnostics10121019. Diagnostics (Basel). 2020. PMID: 33261174 Free PMC article. Review.
References
-
- Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
-
- Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975–2010. National Cancer Institute; Bethesda, MD: http://seer.cancer.gov/csr/1975_2010/ based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
-
- Cozen W, Katz J, Mack TM. Risk patterns of Hodgkin’s disease in Los Angeles vary by cell type. Cancer Epidemiol Biomark Prev. 1992;1(4):261–8. - PubMed
-
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v10, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] Lyon, France: International Agency for Research on Cancer; 2013. Available from http://globocan.iarc.fr.
-
- Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piros M, Steliarova-Foucher E, Swaminathan R, Ferlay J, editors. Cancer Incidence in Five Continents, Vol X (electronic version) Lyon: IARC; 2013. http://ci5.iarc.fr. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous